RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer Cells

Cancer Research
Matthias IlmerJody Vykoukal

Abstract

Cancer stem cells (CSC) present a formidable clinical challenge by escaping therapeutic intervention and seeding tumors through processes that remain incompletely understood. Here, we describe small subpopulations of pancreatic cancer cells with high intrinsic Wnt activity (Wnt(high)) that possess properties indicative of CSCs, including drug resistance and tumor-initiating capacity, whereas cell populations with negligible Wnt activity (Wnt(low)) preferentially express markers of differentiation. Spontaneous response to extrinsic Wnt signals induces signaling networks comprising ERK1/2 and epithelial-mesenchymal transition that subsequently confer cancer stemness traits to susceptible cells. Wnt enhancer R-Spondin 2 (RSPO2) seems to play a prominent upstream role in regulating this interplay. In this context, Wnt(high) cells were more likely to give rise to Wnt(high) progeny, tended to be more metastatic, and revealed higher levels of RSPO2 expression. Our studies reveal adaptive aspects of pancreatic cancer stemness arising from driver populations of CSCs that misappropriate functional and responsive elements of archetypical self-renewal pathways. Blocking such stemness-promoting pathways in conjunction with established chemo...Continue Reading

References

Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
Feb 20, 2007·Current Opinion in Cell Biology·Riccardo Fodde, Thomas Brabletz
Nov 6, 2007·PloS One·Marina Pasca di MaglianoMatthias Hebrok
Nov 21, 2007·Current Opinion in Biotechnology·Laurie E Ailles, Irving L Weissman
Nov 26, 2009·Nature Cell Biology·Ulrich WellnerThomas Brabletz
Feb 27, 2010·PloS One·Christophe Fuerer, Roel Nusse
Apr 27, 2010·Nature Cell Biology·Louis VermeulenJan Paul Medema
Dec 9, 2010·Nature Biotechnology·Mathias UhlenFredrik Ponten
Jun 17, 2011·Nature·Jan Paul Medema, Louis Vermeulen
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Apr 4, 2012·Cancer Treatment Reviews·Malcolm R AlisonLinda J Nicholson
Apr 13, 2012·Science Signaling·Daniele Guardavaccaro, Hans Clevers
May 5, 2012·Seminars in Cancer Biology·Christina Scheel, Robert A Weinberg
May 12, 2012·Nature Reviews. Cancer·Thomas Brabletz
May 24, 2012·The EMBO Journal·Jurian Schuijers, Hans Clevers
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Zhao-Qiu WuStephen J Weiss
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Austin GurneyTimothy Hoey
Aug 17, 2012·Nature·Somasekar SeshagiriFrederic J de Sauvage
Feb 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Liang JinHsun Teresa Ku
Jun 14, 2013·Cancer Research·Yaqing ZhangMarina Pasca di Magliano
Nov 10, 2013·Nature Medicine·Wai Leong Tam, Robert A Weinberg
Jan 31, 2014·Nature Communications·Changjie WuXincheng Lu

❮ Previous
Next ❯

Citations

Dec 15, 2015·Expert Review of Anticancer Therapy·Ivonne RegelJörg Kleeff
May 23, 2015·International Journal of Oncology·Agnès GarnierMatthias Ilmer
Jan 15, 2016·Molecular Biology of the Cell·Yuki NiwaSiro Simizu
May 5, 2017·British Journal of Cancer·F CoussyI Bièche
Nov 4, 2017·Medical Sciences : Open Access Journal·Bernhard W RenzMatthias Ilmer
Oct 27, 2018·Journal of Cellular Biochemistry·Haibo ZhangHongbo Wei
Sep 5, 2019·International Journal of Molecular Sciences·Monish Ram MakenaKartick C Pramanik
Jul 25, 2018·Oncotarget·Eckhard U AltReza Izadpanah
Apr 30, 2017·Oncology Letters·Manu Gnanamony, Christopher S Gondi
Dec 14, 2016·BioMed Research International·Hang YinHailin Liu
Oct 20, 2018·Cancer Cell International·Si LiuXiaohua Jiang
Dec 4, 2019·Molecular Pharmacology·Zheng Zhong, David M Virshup
Sep 29, 2020·Frontiers in Oncology·Asunción Espinosa-SánchezAmancio Carnero
Jan 20, 2017·Experimental and Therapeutic Medicine·Likun YanRuiting Liu
Dec 2, 2015·Genes & Cancer·Matthias Ilmer, David Horst
Aug 1, 2015·Molecular Cancer Research : MCR·Michael D ArensmanDavid W Dawson
Oct 31, 2015·Molecular Cancer Therapeutics·Matthias IlmerMichael Berger
Dec 31, 2020·Cell Reports Medicine·Neda JabbariQiang Tian
Oct 23, 2016·Trends in Endocrinology and Metabolism : TEM·Timothy R Donahue, David W Dawson
May 11, 2021·Frontiers in Cell and Developmental Biology·Vivek KumarB S Dwarakanath
May 18, 2021·Frontiers in Cell and Developmental Biology·Kristina Y Aguilera, David W Dawson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
John D O'FlahertyKenneth O'Byrne
Frontiers in Genetics
Ryou-U TakahashiTakahiro Ochiya
© 2021 Meta ULC. All rights reserved